Levosalbutamol
Levosalbutamol is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target beta-2 adrenergic receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Levalbuterol, Xopenex (discontinued: Levalbuterol, Xopenex)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Levalbuterol tartrate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| XOPENEX HFA | Lupin Research | N-021730 RX | 2005-03-11 | 1 products, RLD, RS |
Levalbuterol hydrochloride
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| XOPENEX | Hikma Pharmaceuticals | N-020837 DISCN | 1999-03-25 | 4 products, RLD |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| levalbuterol | ANDA | 2024-06-26 |
| levalbuterol hydrochloride | ANDA | 2015-07-15 |
| levalbuterol inhalation | ANDA | 2014-09-16 |
| levalbuterol inhalation solution | ANDA | 2020-04-23 |
| levalbuterol tartrate hfa inhalation | NDA authorized generic | 2024-01-15 |
| tetracycline hydrochloride | ANDA | 2016-05-20 |
| xopenex | New Drug Application | 2022-09-14 |
| xopenex hfa | New Drug Application | 2024-01-01 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| bronchial spasm | — | D001986 | — |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
646 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Asthma | D001249 | EFO_0000270 | J45 | 19 | 57 | 92 | 68 | 76 | 309 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 5 | 17 | 52 | 32 | 48 | 152 |
| Obstructive lung diseases | D008173 | HP_0006536 | — | 2 | 14 | 48 | 21 | 34 | 117 |
| Lung diseases | D008171 | HP_0002088 | J98.4 | 3 | 13 | 46 | 23 | 25 | 109 |
| Healthy volunteers/patients | — | — | — | 13 | 1 | — | 2 | 13 | 29 |
| Bronchiolitis | D001988 | HP_0011950 | — | 3 | 3 | — | 5 | 13 | 24 |
| Respiratory aspiration | D053120 | EFO_1001839 | — | 2 | 1 | 5 | 6 | 4 | 18 |
| Status asthmaticus | D013224 | — | — | 2 | 5 | 4 | 4 | 5 | 17 |
| Bronchial spasm | D001986 | — | — | — | 2 | 4 | 3 | 3 | 12 |
| Respiratory sounds | D012135 | HP_0010307 | R06.1 | — | 1 | 1 | 4 | 4 | 10 |
Show 46 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | — | 2 | — | 10 | 12 |
| Fibrosis | D005355 | — | — | 1 | — | 2 | — | 8 | 11 |
| Hypertension | D006973 | EFO_0000537 | I10 | 1 | 2 | 1 | — | 2 | 6 |
| Bronchiectasis | D001987 | HP_0002110 | J47 | — | — | 2 | — | 3 | 5 |
| Acute lung injury | D055371 | EFO_0004610 | — | 2 | 2 | 1 | — | 1 | 5 |
| Respiratory distress syndrome | D012128 | EFO_1000637 | J80 | 2 | 2 | 1 | — | 1 | 5 |
| Lung injury | D055370 | — | S27.30 | — | 2 | 1 | — | 2 | 4 |
| Bronchial hyperreactivity | D016535 | — | — | — | — | 1 | — | 3 | 4 |
| Wounds and injuries | D014947 | — | T14.8 | — | 2 | 1 | — | 1 | 3 |
| Chronic disease | D002908 | — | — | — | — | 3 | — | — | 3 |
Show 18 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cough | D003371 | HP_0012735 | R05 | — | 1 | — | — | 1 | 2 |
| Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | 1 | 1 | — | — | — | 2 |
| Discoid lupus erythematosus | D008179 | — | — | — | 2 | — | — | — | 2 |
| Systemic lupus erythematosus | D008180 | HP_0002725 | M32 | — | 2 | — | — | — | 2 |
| Sclerosis | D012598 | — | — | — | 1 | — | — | 1 | 2 |
| Lymphangioleiomyomatosis | D018192 | — | J84.81 | 1 | 1 | — | — | — | 1 |
| Viral bronchiolitis | D001990 | — | — | — | 1 | — | — | — | 1 |
| Brain death | D001926 | — | G93.82 | — | 1 | — | — | — | 1 |
| Pulmonary edema | D011654 | EFO_1001134 | J81 | — | 1 | — | — | — | 1 |
| Amyotrophic lateral sclerosis | D000690 | HP_0007354 | G12.21 | — | 1 | — | — | — | 1 |
Show 2 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Covid-19 | D000086382 | — | — | 1 | — | — | — | 4 | 5 |
| Cardiovascular diseases | D002318 | HP_0001626 | — | 1 | — | — | — | 3 | 4 |
| Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 2 | — | — | — | 1 | 3 |
| Ciliary motility disorders | D002925 | EFO_0003900 | — | 1 | — | — | — | 2 | 3 |
| Syndrome | D013577 | — | — | 2 | — | — | — | — | 2 |
| Sickle cell anemia | D000755 | EFO_0000697 | D57 | 1 | — | — | — | 1 | 2 |
| Dyskinesias | D020820 | HP_0002310 | G24 | 1 | — | — | — | 1 | 2 |
| Major depressive disorder | D003865 | EFO_0003761 | F22 | 1 | — | — | — | — | 1 |
| Depressive disorder | D003866 | EFO_1002014 | F32.A | 1 | — | — | — | — | 1 |
| Cicatrix | D002921 | HP_0100699 | L90.5 | 1 | — | — | — | — | 1 |
Show 4 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Smoking | D012907 | EFO_0004318 | — | — | — | — | — | 4 | 4 |
| Airway remodeling | D056151 | — | — | — | — | — | — | 3 | 3 |
| Pneumonia | D011014 | EFO_0003106 | — | — | — | — | — | 3 | 3 |
| Emphysema | D004646 | EFO_0000464 | J43 | — | — | — | — | 3 | 3 |
| Infections | D007239 | EFO_0000544 | — | — | — | — | — | 3 | 3 |
| Chronic bronchitis | D029481 | — | J42 | — | — | — | — | 2 | 2 |
| Muscular dystrophies | D009136 | HP_0003560 | G71.0 | — | — | — | — | 2 | 2 |
| Child mortality | D046688 | — | — | — | — | — | — | 2 | 2 |
| Artificial respiration | D012121 | — | — | — | — | — | — | 1 | 1 |
| Pulmonary atelectasis | D001261 | — | J98.1 | — | — | — | — | 1 | 1 |
Show 73 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Levosalbutamol |
| INN | levosalbutamol |
| Description | (R)-salbutamol is an albuterol. |
| Classification | Small molecule |
| Drug class | anti-inflammatory agents (salicylic acid derivatives) |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1 |
Identifiers
| PDB | — |
| CAS-ID | 34391-04-3 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1002 |
| ChEBI ID | 8746 |
| PubChem CID | 123600 |
| DrugBank | DB13139 |
| UNII ID | EDN2NBH5SS (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
ADRB2
ADRB2
Organism
Homo sapiens
Gene name
ADRB2
Gene synonyms
ADRB2R, B2AR
NCBI Gene ID
Protein name
beta-2 adrenergic receptor
Protein synonyms
adrenergic, beta-2-, receptor, surface, adrenoceptor beta 2 surface, Beta-2 adrenoceptor, Beta-2 adrenoreceptor, catecholamine receptor
Uniprot ID
Mouse ortholog
Adrb2 (11555)
beta-2 adrenergic receptor (Q8BH38)
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Levosalbutamol
+
Levalbuterol
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 633 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,935 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use